Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 22 for “"OVCAR3"”.

  1. Integrated positional and functional approach for identifying ovarian cancer tumour suppressor genes on chromosome 11p

    … TSGs in these regions. Ovarian cancer cell line OVCAR3 has lost a whole copy of chromosome 11. The remaining copy is fragmented, rearranged and duplicated. Transfer of normal chromosome 11 into OVCAR3 by Microcell Mediated Chromosome Transfer (MMCT) produced microcell hybrids that display …

    edinburgh Repository record for Integrated positional and functional approach for identifying ovarian cancer tumour suppressor genes on chromosome 11p (opens in a new tab)

  2. Investigating Phenotypic Changes in Response to Drug Treatments in Epithelial Ovarian Cancer Using a Novel Si-TiB2 Micropatterned Substrate

    … and charge gradient. For EOC cell lines, OVCAR3 (low invasiveness) and SKOV3 (high invasiveness), the Si-TiB2 micropatterned substrate supported cell proliferation and maintained viability, and 3D aggregation for SKOV3 cells. Treating SKOV3 aggregates and OVCAR3 monolayers on patterned …

    houston Repository record for Investigating Phenotypic Changes in Response to Drug Treatments in Epithelial Ovarian Cancer Using a Novel Si-TiB2 Micropatterned Substrate (opens in a new tab)

  3. An investigation of novel interacting drug combinations in the treatment of high-grade serous ovarian cancer

    … tumour formation as an in vivo-like platform. OVCAR3 CAM tumours retained key histopathological features of HGSOC including similar morphology and relative expression of biomarkers. The pharmacodynamic responses of OVCAR3 CAM tumour to cisplatin and copanlisib were determined by PARP cleavage …

    qu-belfast Repository record for An investigation of novel interacting drug combinations in the treatment of high-grade serous ovarian cancer (opens in a new tab) Embargoed until 2029-07-31

  4. The characterisation of ovarian cancer stem cells and the effects of Chinese herbal medicines

    … documents the presence of SP in SK-OV-3 and OVCAR3 ovarian cancer cell lines. It is the first report on the upregulated genes in the SP cells of SK-OV-3 and OVCAR3. SP cells are smaller than non-SP population (NSP) cells and SP cells have fewer organelles inside the cytoplasm than do NSP …

    unsw Repository record for The characterisation of ovarian cancer stem cells and the effects of Chinese herbal medicines (opens in a new tab)

  5. The role of molecular weight of hyaluronan in ovarian cancer stem cell signalling pathways and chemoresistance

    … cancer cell lines (CaOV3, OV90, ES-2, SKOV3 and OVCAR3). Other studies have found different molecular weight HA effect populations of cancer cells selected for CSC features. To assess this, we overexpressed the intracellular domain of NOTCH3 (NICD3), a protein involved in maintenance of CSC …

    adelaide Repository record for The role of molecular weight of hyaluronan in ovarian cancer stem cell signalling pathways and chemoresistance (opens in a new tab)

  6. THE DEVELOPMENT OF CHIMERIC ANTIGEN RECEPTOR (CAR) B-CELL THERAPY AND 3D TISSUE RECONSTRUCTION OF PYMT MOUSE MAMMARY TISSUE

    … capability in eliminating ovarian cancer cells (OVCAR3) when compared to the regular B cells. This result suggests that CAR-B cells can potentially be a new category of immunotherapy in cancer treatment. In addition, to better understand breast cancer progression in situ in 3D, I reconstructed …

    jhu Repository record for THE DEVELOPMENT OF CHIMERIC ANTIGEN RECEPTOR (CAR) B-CELL THERAPY AND 3D TISSUE RECONSTRUCTION OF PYMT MOUSE MAMMARY TISSUE (opens in a new tab) Embargoed until 2027-05-01

  7. Novel Micropatterned Substrate for Investigation of Ovarian Cancer Aggregate Formation and Response to Epigenetic Drug Therapy

    … self-assembly of cells into 3D aggregates. OVCAR3 and SKOV3 cell lines were used in the absence/presence of pan-genome epigenetic drugs such as suberoylanilide hydroxamic acid (SAHA). The micropatterned substrate supported cell proliferation, migration, and aggregate formation while …

    houston Repository record for Novel Micropatterned Substrate for Investigation of Ovarian Cancer Aggregate Formation and Response to Epigenetic Drug Therapy (opens in a new tab)

  8. Photoactivatable Organic and Inorganic Nanoparticles in Cancer Therapeutics and Biosensing

    … nanoparticles (FNPs) were studied in OVCAR3 (ovarian cancer cell line) as FR+, MIA PaCa2 (pancreatic cell line) as FR-, and A549 (lung cancer cell line) having marginal FR expression. Complete selectivity of the FNPs towards the FR+ cell line was found. Quantification of PDT results by …

    ucf Repository record for Photoactivatable Organic and Inorganic Nanoparticles in Cancer Therapeutics and Biosensing (opens in a new tab)

  9. Genotoxic Stress Causes Activation of Akt via Ca2+/Calmodulin-Dependent Protein Kinase Kinase 2 Pathway

    … the Akt downstream target PRAS40. Treatment of OVCAR3 cells with the intracellular calcium chelator, BAPTA-AM, or inhibition with the calmodulin inhibitor W-7 also decreased phosphorylation of Akt verifying that the action of CaMKK2 is reliant on its Ca2+/CaM-dependence.

    buffalo Repository record for Genotoxic Stress Causes Activation of Akt via Ca2+/Calmodulin-Dependent Protein Kinase Kinase 2 Pathway (opens in a new tab)

  10. Targeting multiple signaling pathways in ovarian cancer by diindolylmethane

    … that DIM reduces the proliferation of SKOV3, OVCAR3 and TOV-21G ovarian cancer cells in a concentration and time dependent manner. The growth suppressive effects of DIM were mediated by G2/M cells cycle arrest that was regulated by the activation of Chk2 in response to ROS mediated DNA damage. …

    ttu Repository record for Targeting multiple signaling pathways in ovarian cancer by diindolylmethane (opens in a new tab)

  11. The roles of betacellulin in epithelial ovarian cancer migration and proliferation

    … genes. Epithelial ovarian cancer cell lines OVCAR3, OVCAR4, OVCAR5 and SKOV3 were used as study models. Cancer cell migration was assessed by transwell assays; and cell proliferation was measured by MTT assays. Our results showed that betacellulin induced epithelial ovarian cancer cell …

    ubc Repository record for The roles of betacellulin in epithelial ovarian cancer migration and proliferation (opens in a new tab) Download PDF for The roles of betacellulin in epithelial ovarian cancer migration and proliferation (opens in a new tab)

  12. CANCER AND QUIESCENCE: INVESTIGATING HOW THE DREAM COMPLEX AND RETINOBLASTOMA REGULATE THE CELL CYCLE

    … cell line responds to CDK inhibition but the OVCAR3 ovarian cancer cell line does not respond to CDK inhibition. Using western blot and expression analysis, we evaluated pRb and p130 response to CDK inhibition in SKOV3 cells, as compared to normal human foreskin fibroblasts (HFFs). We observed …

    mtu Repository record for CANCER AND QUIESCENCE: INVESTIGATING HOW THE DREAM COMPLEX AND RETINOBLASTOMA REGULATE THE CELL CYCLE (opens in a new tab)

  13. Liposomal Combination Drug and siRNA Delivery to Combat Drug-Resistant Ovarian Cancer

    … of drug resistance in paclitaxel-resistant OVCAR3-TR ovarian cancer cells. Two combinatorial, cationic liposome delivery systems were designed and synthesized via the lipid film hydration method. Liposomes were characterized for size, surface charge, stability, and loading efficiencies. We …

    clemson Repository record for Liposomal Combination Drug and siRNA Delivery to Combat Drug-Resistant Ovarian Cancer (opens in a new tab)

  14. Investigation of the role of Receptor Tyrosine Kinase like Orphan Receptors (RORs) in epithelial ovarian cancer

    … using a siRNA approach in an HGSOC cell line OVCAR3 revealed functional roles of ROR1 and ROR2 in migration and invasion. Moreover, silencing both receptors simultaneously greatly inhibited the ability of ovarian cancer cells to proliferate and spread (publication 1). A subsequent assessment …

    unsw Repository record for Investigation of the role of Receptor Tyrosine Kinase like Orphan Receptors (RORs) in epithelial ovarian cancer (opens in a new tab)

  15. Evaluating Fty720 As An Anticancer Agent In Models Of Ovarian Cancer

    … inhibitors JQ1 or iBET-762 was synergistic in OVCAR3 and CAOV3 HGS cell lines. Our data suggest FTY720 warrants further investigation as a potential treatment strategy for ovarian cancer.

    uab Repository record for Evaluating Fty720 As An Anticancer Agent In Models Of Ovarian Cancer (opens in a new tab)

  16. Significance of Altered Golgi Apparatus and Cell Fusion Events in Ovarian Cancer Cells

    … cells but had no effect on other cell lines (OVCAR3 and SKOV3) tested. Cells exposed to cisplatin during migration showed significantly depolarised Golgi, reduced cell motility and wound healing capacity. Protein trafficking was also significantly reduced in response to cisplatin. Cell-line …

    oxford-brookes Repository record for Significance of Altered Golgi Apparatus and Cell Fusion Events in Ovarian Cancer Cells (opens in a new tab) Download PDF for Significance of Altered Golgi Apparatus and Cell Fusion Events in Ovarian Cancer Cells (opens in a new tab)

  17. Design and development of novel tools for the screening and identification of inhibitors of HER receptor family and NFR2 for ovarian cancer therapy

    … glutathione and enhanced cytotoxicity in PEO1, OVCAR3, SKOV3 and MCF7-AREc32 cell lines. This explained the crosstalk mechanism between HER receptor family and NRF2 and the role of NRF2 in drug resistance and as a relevant anti-cancer target which opens up novel avenues of targeting HER receptor …

    abertay Repository record for Design and development of novel tools for the screening and identification of inhibitors of HER receptor family and NFR2 for ovarian cancer therapy (opens in a new tab) Download PDF for Design and development of novel tools for the screening and identification of inhibitors of HER receptor family and NFR2 for ovarian cancer therapy (opens in a new tab)

  18. Investigations into the roles of Histamine Receptor H1 and extracellular vesicles in ovarian cancer cell behaviour

    … was modulated in three OC cell lines (SKOV3, OVCAR3 and OVCAR5), via siRNA transfection, chemical activation (via histamine) or inhibition (via chlorpheniramine) and its effect on cellular behaviour was evaluated through different in vitro assays. Results showed that HRH1: 1) does not modulate …

    oxford-brookes Repository record for Investigations into the roles of Histamine Receptor H1 and extracellular vesicles in ovarian cancer cell behaviour (opens in a new tab) Download PDF for Investigations into the roles of Histamine Receptor H1 and extracellular vesicles in ovarian cancer cell behaviour (opens in a new tab)

  19. Targeted alpha therapy for epithelial ovarian cancer

    … cell inoculation of the ovarian cancer cell line OVCAR3. The treatment efficacy of 213Bi-Herceptin was tested at a 2 days post-subcutaneous breast cancer cell BT474 inoculation. Mice were injected (i.p) with various concentrations of alpha conjugates (AC). Changes in cancer progression were …

    unsw Repository record for Targeted alpha therapy for epithelial ovarian cancer (opens in a new tab)

Page 1 of 2